The Tests That Determine If You Qualify for Home Oxygen Support

Home oxygen qualification tests determine whether a person has medically significant low blood oxygen and whether supplemental oxygen is likely to improve safety, function, or survival. Clinicians generally use pulse oximetry and, when needed, an arterial blood gas test to measure oxygenation at rest, during exercise, or while sleeping. In the United States, Medicare commonly covers oxygen when resting arterial oxygen pressure is 55 mm Hg or less or oxygen saturation is 88% or less, with additional criteria for exertional and nocturnal hypoxemia. The American Thoracic Society, Centers for Medicare & Medicaid Services, and professional pulmonary guidelines emphasize that testing must occur in a stable clinical state and must be interpreted alongside the patient’s symptoms, diagnosis, and treatment plan.

Qualification Tests + Home Oxygen Support

Home oxygen qualification tests are objective assessments used to document hypoxemia, meaning an abnormally low concentration of oxygen in arterial blood. The American Thoracic Society defines home oxygen therapy as oxygen prescribed for use outside a hospital or other medical facility, typically through a concentrator, compressed-gas cylinder, or liquid-oxygen system. Qualification is not based solely on breathlessness: a person may feel short of breath while having an oxygen level above the coverage threshold, while another person may have clinically important hypoxemia with relatively few symptoms.

The main testing categories are resting oxygen assessment, arterial blood gas analysis, exertional testing, and overnight or sleep testing. These categories correspond to different forms of hypoxemia: chronic resting hypoxemia, exercise-induced hypoxemia, and sleep-related hypoxemia. The result can affect whether oxygen is prescribed continuously, only during activity, only during sleep, or not at all.

Resting pulse oximetry

Resting pulse oximetry is a noninvasive screening and qualification test that estimates peripheral oxygen saturation, commonly reported as SpO2. A small sensor placed on a finger, earlobe, or other suitable site uses light absorption to estimate the percentage of hemoglobin carrying oxygen. In Medicare’s standard Group I coverage pathway, an oxygen saturation of 88% or less at rest while breathing room air can support coverage when the test is properly documented and the patient meets the applicable clinical requirements.

A pulse-oximeter reading is an estimate rather than a direct blood measurement. Cold hands, poor circulation, movement, nail products, irregular pulse, skin pigmentation-related device limitations, and an improperly positioned sensor can affect accuracy. The U.S. Food and Drug Administration advises that pulse oximeter readings should be interpreted with symptoms and other clinical information rather than treated as an isolated diagnosis.

Arterial blood gas testing

An arterial blood gas, or ABG, measures oxygen tension, carbon dioxide tension, and blood acidity from an arterial blood sample, usually taken from the wrist. It is more invasive than pulse oximetry but can provide a direct measurement of PaO2 and information about ventilation and acid-base balance. Under Medicare’s Group I criteria, a PaO2 of 55 mm Hg or less while breathing room air at rest generally corresponds to a qualifying level of hypoxemia.

ABG testing is particularly useful when the pulse-oximeter result is borderline, when carbon dioxide retention is a concern, or when the oxygen saturation reading does not fit the clinical picture. It may also be used when a payer requires stronger documentation. Because oxygen administration changes the result, the clinician must document the oxygen flow rate or fraction of inspired oxygen used during the test.

Resting Hypoxemia + Long-Term Oxygen Qualification

Resting hypoxemia is low blood oxygen measured while the patient is awake, clinically stable, and at rest. It is the clearest traditional indication for long-term oxygen therapy. The American Thoracic Society’s 2020 clinical practice guideline describes severe chronic resting hypoxemia as PaO2 of 55 mm Hg or less or SpO2 of 88% or less, or slightly higher values when signs of pulmonary hypertension, congestive heart failure, or secondary erythrocytosis are present.

Medicare Group I criteria

Medicare’s National Coverage Determination identifies Group I qualification when testing shows PaO2 at or below 55 mm Hg or oxygen saturation at or below 88% in one of several settings: at rest while awake, during sleep, or during exercise when the awake resting value is higher but falls to the qualifying level. For exercise coverage, documentation generally must show that oxygen corrects or improves the exercise-related hypoxemia.

• Resting testing is performed while the patient is awake and breathing room air, unless the clinician documents why room-air testing is not appropriate.
• Exercise testing may compare room-air saturation with saturation while using oxygen.
• Sleep testing may document a qualifying fall in oxygen saturation or PaO2 during sleep.
• The medical record should identify the diagnosis, test conditions, oxygen flow rate, and prescribing clinician.

Medicare Group II criteria

Group II applies to somewhat higher oxygen levels, generally PaO2 of 56 to 59 mm Hg or oxygen saturation of 89%, when an additional condition is documented. Examples include dependent edema suggesting congestive heart failure, pulmonary hypertension or cor pulmonale, or erythrocytosis with a hematocrit above 56%. These criteria illustrate why a numerical result alone does not always determine coverage.

Private insurers, Medicaid programs, Veterans Health Administration programs, and oxygen suppliers may use different documentation rules or authorization procedures. A patient who meets a clinical guideline may still need a qualifying test performed in a specified way for insurance reimbursement.

Exercise Testing + Ambulatory Oxygen Qualification

Exercise testing evaluates whether oxygen levels fall when the body’s demand increases. The most common standardized assessment is a six-minute walk test, although a supervised corridor walk, treadmill test, or other functional assessment may be used. The clinician records baseline saturation, the activity performed, the lowest saturation reached, symptoms, distance, pulse rate, and the response to supplemental oxygen.

Six-minute walk testing

A six-minute walk test measures the distance a patient can walk on a flat course in six minutes while clinicians monitor oxygen saturation and symptoms. A fall to 88% or below during exertion may support ambulatory oxygen qualification under Medicare when the test is conducted and documented according to coverage requirements. The test should be supervised, reproducible, and linked to a treatment question such as whether oxygen enables safer or more sustained activity.

The test is not simply a pass-or-fail exercise. Clinicians compare room-air performance with performance while using oxygen at a specified flow rate. If oxygen raises saturation and improves functional tolerance, the record provides stronger evidence that ambulatory oxygen is useful. A patient should not independently increase the flow rate during testing or daily activity without medical instruction.

Exercise-induced hypoxemia

Exercise-induced hypoxemia means oxygen saturation drops during physical activity even though resting oxygenation is above the severe threshold. It can occur with chronic obstructive pulmonary disease, interstitial lung disease, pulmonary hypertension, cystic fibrosis, and other cardiopulmonary disorders. The American Thoracic Society conditionally recommends ambulatory oxygen for some adults with chronic lung disease and severe exertional hypoxemia, but it also notes that benefits and burdens vary by patient.

Potential benefits include improved exercise tolerance, fewer activity-related oxygen drops, and greater ability to participate in rehabilitation or daily tasks. Burdens include equipment weight, tubing hazards, cost, reduced mobility, skin irritation, and fire risk. The prescription should therefore specify when oxygen is needed, the flow setting or device mode, and how the patient should monitor symptoms.

Sleep Testing + Nocturnal Oxygen Qualification

Sleep testing assesses oxygenation when breathing patterns, body position, and airway function change during sleep. A patient may have acceptable daytime saturation but experience repeated or prolonged oxygen desaturation overnight. Testing may use overnight pulse oximetry, a formal polysomnogram, or another sleep evaluation, depending on the suspected condition and payer requirements.

Overnight oximetry

Overnight oximetry records oxygen saturation continuously or at frequent intervals during sleep. The report may show the lowest saturation, the percentage of recording time below a specified level, and the pattern of desaturation. Medicare’s coverage framework includes sleep-related qualification when PaO2 or oxygen saturation falls to the required level during sleep, even if the awake value is higher, provided other conditions are met.

Overnight oxygen is not automatically the correct treatment for every nighttime desaturation. Obstructive sleep apnea, for example, may require positive airway pressure therapy, and oxygen alone may not correct airway obstruction or carbon dioxide retention. A sleep clinician may therefore recommend diagnostic polysomnography or treatment with continuous positive airway pressure before deciding whether oxygen is appropriate.

Sleep-disordered breathing and carbon dioxide retention

Sleep-disordered breathing can cause intermittent oxygen drops and changes in carbon dioxide. Patients with obesity hypoventilation, neuromuscular disease, severe chronic obstructive pulmonary disease, or other ventilatory disorders may need carbon dioxide assessment in addition to oxygen saturation monitoring. An ABG or transcutaneous carbon dioxide measurement can help prevent treating low oxygen while overlooking inadequate ventilation.

Clinical Stability + Validating Oxygen Test Results

Clinical stability means the oxygen assessment reflects the patient’s usual condition rather than a temporary crisis. Testing during an acute infection, asthma flare, heart-failure exacerbation, pulmonary embolism, or immediately after hospitalization may show oxygen levels that improve after treatment. Clinicians often reassess oxygen needs after recovery, and Medicare rules include separate requirements for testing conducted during or after an inpatient stay.

Medication and treatment conditions

The medical record should state whether the patient was breathing room air, receiving supplemental oxygen, or using prescribed therapies during the assessment. Bronchodilators, diuretics, antibiotics, corticosteroids, pulmonary rehabilitation, and positive airway pressure can affect oxygenation. A valid comparison may require testing both without oxygen and with oxygen at the proposed setting, provided removing oxygen is clinically safe.

Factors that can distort pulse-oximeter readings

• Poor peripheral circulation or low body temperature can reduce signal quality.
• Motion, tremor, or an irregular pulse can produce unstable readings.
• Nail polish, artificial nails, and incorrect sensor placement may interfere with measurement.
• Some devices may perform differently across skin tones, especially at low oxygen levels.
• Carbon monoxide exposure can cause a pulse oximeter to overestimate oxygenation, making ABG or co-oximetry important when exposure is suspected.

A single borderline reading should generally be repeated or confirmed rather than used in isolation. The World Health Organization and the Food and Drug Administration both emphasize appropriate device use, signal quality, and clinical interpretation. Patients should report worsening breathlessness, chest pain, confusion, blue or gray lips, or severe weakness urgently, regardless of the displayed number.

Prescription Decision + Home Oxygen Safety

A qualifying test supports a prescription but does not determine every detail of treatment. The clinician must decide the oxygen source, flow rate, duration, portability needs, target saturation, and reassessment schedule. Long-term oxygen is commonly considered for patients with severe chronic resting hypoxemia, while exertional or nocturnal oxygen may be prescribed for a narrower period of the day.

Equipment and usage instructions

Equipment may include a stationary oxygen concentrator, portable concentrator, compressed-gas cylinders, or liquid oxygen. Device selection depends on prescribed flow, mobility, travel requirements, power availability, and whether the patient needs continuous-flow or pulse-dose oxygen. Pulse-dose devices may not deliver sufficient oxygen for every patient, particularly during sleep or rapid breathing, so suitability should be verified clinically.

Fire and medication safety

Oxygen supports combustion even though it is not itself flammable. The National Fire Protection Association and respiratory-care organizations advise keeping oxygen away from cigarettes, candles, gas flames, sparks, and heat sources. Petroleum-based products should not be used around oxygen equipment unless specifically approved, and tanks must be secured upright to prevent falling.

Patients should request written instructions, understand how to check equipment, maintain backup supplies when appropriate, and know whom to call during a power outage or equipment failure. Follow-up testing is important because oxygen needs can change after smoking cessation, weight change, disease treatment, hospitalization, or recovery from an acute illness.

Real-World Example + Interpreting Qualification Results

Consider a patient with stable interstitial lung disease whose resting room-air saturation is 92% but falls to 84% during a supervised six-minute walk. If saturation improves to 90% or higher with the prescribed oxygen setting and the patient walks farther or reports less activity-related distress, the clinician may prescribe ambulatory oxygen. This case differs from a patient whose resting saturation is 86%, whose results may support continuous or near-continuous oxygen after confirmation and evaluation of the underlying disease.

A third patient may have a daytime saturation of 93% but repeated overnight desaturations. That patient may need evaluation for sleep apnea or hypoventilation before oxygen is prescribed. These examples show why the timing and conditions of the test matter as much as the number itself.

A useful visual summary for clinicians and patients is a three-column chart comparing testing condition, qualifying result, and likely oxygen pattern: awake at rest for continuous oxygen consideration; supervised exertion for ambulatory oxygen; and sleep monitoring for nocturnal oxygen or sleep-disorder evaluation. The chart should also identify whether oxygen corrected the abnormality and whether a reassessment date was scheduled.

Conclusion + Next Steps for Oxygen Qualification

Home oxygen support is determined through qualification tests that document low oxygen at rest, during exercise, or during sleep. Resting pulse oximetry and arterial blood gas testing assess chronic resting hypoxemia; six-minute walk or comparable exercise testing identifies exertional hypoxemia; and overnight oximetry or polysomnography evaluates sleep-related oxygen changes. Medicare’s commonly used thresholds are SpO2 of 88% or less or PaO2 of 55 mm Hg or less, with additional Group II and sleep or exercise pathways.

Accurate qualification depends on clinical stability, reliable equipment, documented testing conditions, appropriate confirmation of borderline results, and evaluation of competing problems such as sleep apnea or carbon dioxide retention. Anyone being evaluated should ask the prescribing clinician which test is needed, whether it will be performed on room air and with oxygen, what coverage rules apply, and when oxygen needs will be reassessed. Further reading should include the American Thoracic Society home oxygen guideline, Medicare’s coverage determination, and FDA guidance on pulse oximeter limitations.

Sources: Centers for Medicare & Medicaid Services, National Coverage Determination 240.2, Home Use of Oxygen, https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=169; Jacobs, S. S., et al., American Thoracic Society Clinical Practice Guideline: Home Oxygen Therapy for Adults with Chronic Lung Disease, American Journal of Respiratory and Critical Care Medicine, 2020, https://doi.org/10.1164/rccm.202 exc; U.S. Food and Drug Administration, Pulse Oximeter Accuracy and Limitations, https://www.fda.gov/consumers/consumer-updates/fda-informs-public-about-possible-accuracy-concerns-pulse-oximeters; American Thoracic Society, Six-Minute Walk Test, https://www.thoracic.org/statements/resources/pfet/six-minute-walk-test.pdf; National Fire Protection Association, Home Oxygen Safety, https://www.nfpa.org/education-and-research/home-fire-safety/oxygen-safety